IP Library › Assignment 029422/0128
Patent Assignment
Reel/Frame 029422/0128

Assignment of Assignor's Interest

Recorded: 2012-12-06 Pages: 4
Assignors
ZABLOCKI, JEFF
Executed: 2007-08-02
ELZEIN, ELFATIH
Executed: 2007-08-02
Assignee
CV THERAPEUTICS, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Property (1)
Monohydrate of (1-{9-[(4S,2R,3R,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-6-Aminopurin-2-Yl}Pyrazol-4-Yl)-N-Methylcarboxamide
Patent: 8,524,883 →
Application: 13/333,872 →
Publication: US 2012/0165350
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Dec 6, 2012
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 029422/0242 →
Assignment of Assignor's Interest Dec 6, 2012
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 029422/0265 →
Assignment of Assignor's Interest Jan 29, 2013
From: LEMONS, TRAVIS; SEEMAYER, ROBERT
To: GILEAD SCIENCES, INC.
Reel/Frame 029716/0839 →